Skip to main content
PMC home page
International Journal of Methods in Psychiatric Research logoLink to International Journal of Methods in Psychiatric Research
. 2006 Mar 24;12(4):208–228. doi: 10.1002/mpr.158

Aims, design and methods of the Smoking and Nicotine Dependence Awareness and Screening (SNICAS) study

Stephan Muehlig 1,✉, Eva Hoch 2, Michael Hoefler 2, David Pittrow 1, Hans‐Ulrich Wittchen 1,2
PMCID: PMC6878365  PMID: 14657977

Abstract

The objectives of the Smoking and Nicotine Dependence Awareness (SNICAS) study are to provide nationally representative data on the prevalence of smoking and smoking dependence of primary care patients and the frequency in which smoking cessation interventions are offered and provided in primary care. With the inclusion of both providers' (doctor) and patients' perspectives, the study also attempts to identify the needs and motivational status for smoking cessation as reported by the patients and as perceived by the doctor.

The Smoking and Nicotine Dependence Awareness study uses a two‐stage epidemiological design. Stage 1 consists of a pre‐study characterization of a nationwide sample of 889 primary care doctors (conservative response rate: 50%). Stage 2 consists of a cross‐sectional assessment of unselected consecutive patients (n = 28,707, conservative response rate: 52.8%) on the study's target day, by means of patient questionnaire and a structured clinical appraisal of each patient by the doctor.

This paper provides an overview of the design and methods of the study, informs about sampling and response rates, and examines whether the study sample could be considered representative of German primary care doctors. Copyright © 2003 Whurr Publishers Ltd.

Keywords: epidemiology, smoking, nicotine dependence, smoking cessation, primary care

Full Text

The Full Text of this article is available as a PDF (2.5 MB).

References

  1. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington P L. Depression and the dynamics of smoking: a national perspective. JAMA 1990; 264: 1541–5. [PubMed] [Google Scholar]
  2. Brandon TH. Negative affect as motivation to smoke. Current Directions in Psychological Science 1994; 3: 33–7. [Google Scholar]
  3. Breslau N, Johnson EO. Predicting smoking cessation and major depression in nicotine‐dependent smokers. American Journal of Public Health 2000; 90 (7): 1122–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. American Psychiatric Association (APA) . Diagnostic and Statistical Manual of Mental Disorders. 4 edn. Washington: American Psychiatric Association, 1994. [Google Scholar]
  5. American Psychiatric Association . Practice guideline for the treatment of patients with nicotine dependence. American Journal of Psychiatry 1996; 153 (suppl. 10): S1–S31. [DOI] [PubMed] [Google Scholar]
  6. Arbeitskreis Rauchen und Gesundheit: Consensus Statement. Eching/München: ÄARG, 1998. [Google Scholar]
  7. Batra A, Buchkremer G. Raucherentwöhnung mit dem Nikotinpflaster. Zeitschrift für Ärztliche Fortbildung 1995; 89: 505–9. [PubMed] [Google Scholar]
  8. Bellach B‐M, Knopf H, Thefeld W. Der Bundes‐Gesundheitssurvey 1997/1998. Das Gesundheitswesen 1998; 60 (suppl. 2): S59–S68. [PubMed] [Google Scholar]
  9. Breslau N, Johnson EO, Hiripi E, Kessler R. Nicotine dependence in the United States – prevalence, trends, and smoking persistence. Arch Gen Psychiatry 2001, 58: 810–16. [DOI] [PubMed] [Google Scholar]
  10. Buchkremer G, Bents H, Horstmann M, Opitz K, Tölle R. Combination of behavioral smoking cessation with transdermal nicotine substitutution. Addictive Behavior 1989; 14: 229–38. [DOI] [PubMed] [Google Scholar]
  11. Buchkremer G, Minneker E, Block M. Smoking‐cessation treatment combining transdermal nicotine substitution with behavioral therapy. Pharmacopsychiatry 1991; 24: 96–102. [DOI] [PubMed] [Google Scholar]
  12. Bühringer G, Körger C, Küfner H, Lieb R, Schütz C, Soyka M, Wittchen H‐U. Suchtforschungsverbund ASAT: Entwicklung von Zuordnungsmodellen für Interventionen bei Substanzstörungen. Sucht 2002; 48 (3): 200–8. [Google Scholar]
  13. Bundesgesundheitssurvey 1997/1998 . Das Gesundheitswesen, Schwerpunktheft 1998, Stuttgart: Thieme, 1998, 60 (suppl 2). [Google Scholar]
  14. Colby SM, Tiffany ST, Shiffman S, Niaura R. Review: are adolescent smokers dependent on nicotine? A review of the evidence. Drug and Alcohol Dependence 2000, 59 (suppl. 1): 83–95. [DOI] [PubMed] [Google Scholar]
  15. Cohen D, Barton G. The cost of society of smoking cessation. Thorax 1998; 53 (suppl. 2): S38–S42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cottler L, Robins LN, Babor T, Helzer J, Towle L, Grant B, Blaine J, Wittchen H‐U, Sartorius N, Burke J, Regier D, Tipp J, Altamura AC, Andrews G, Dingemann R, Droux A, Essau CA, Farmer A, Halikas J, Ingebringsten, Issac M, jenkins P, Kuehne GE, Krause J, Lepine PP, Lykepsos G, Maier W, Pull C, Rubio‐Stipic M, Sandanger I, Smeets R, Tachini G, Tihram M, Torres de la Miranda C. Cross‐cultural reliability and acceptability of the CIDI‐core substance abuse and dependence questions In Stefans CN, Rabavilas AD, Soldatos CR. (eds), Psychiatry: A World Perspective. Amsterdam: Excerpta Medica, 1990, pp. 144–52. [Google Scholar]
  17. Cottler L, Robins LN, Grant B, Blaine J, Towle L, Wittchen H‐U, Sartorius N, Burke J, Regier D, Hezler J, Janca A. The CIDI‐core substance abuse and dependence questions: cross cultural and nosological issues. British Journal of Psychiatry 1991; 159: 653–8. [DOI] [PubMed] [Google Scholar]
  18. Dennis ML. Integrating research and clinical assessment. Measuring client and program needs and outcomes in a changing service environment. NIDA Resource Center for Health Services Research.
  19. De Wit DJ, Aguilar‐Gaziola S, Bijl R, Borges G, Caraveo‐Anduaga JJ, Kessler RC, Kolody B, Merikangas KR, Molnar BE, Vega WA, Walters EE, Wittchen H‐U. Cross‐national comparisons of drug use and drug‐related problems. Addiction (in press).
  20. Etter J‐F, Perneger TV. A comparison of two measures of stage of change for smoking cessation. Addiction 1999; 94(12): 1881–9. [DOI] [PubMed] [Google Scholar]
  21. Fagerström KO, Schneider NG, Lunell E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatment for tobacco withdrawal symptoms. Psychopharmacology 1993; 111: 271–7. [DOI] [PubMed] [Google Scholar]
  22. Fagerström KO. Combined use of nicotine replacement products. Health Values 1994; 18: 15–20. [Google Scholar]
  23. Fiore MC, Bailey WC, Cohen SJ, Dorfmann SF, Goldstein HG, Gritz ER, Heyman RB, Holbrook J. Treating tobacco use and dependence. Clinical practice guideline. Rockville MD: U.S. Department of Health and Human Services. Public Health Services, 2000. [Google Scholar]
  24. Fowler G. Smoking cessation: the role of general practitioners, nurses and pharmacists In Bolliger CT, Fagerström KO. (eds) The Tobacco Epidemic. Progress in Respiratory Research. Basel: Karger, 1997, pp. 165–77. [Google Scholar]
  25. Haustein K‐O. Pharmacotherapy of nicotine dependence. International Journal of Clinical Pharmacology and Therapeutics 2000; 38: 273–90. [DOI] [PubMed] [Google Scholar]
  26. Haustein K‐O. Tabakabhängigkeit – Gesundheitliche Schäden durch das Rauchen. Köln: Deutscher Ärzte‐Verlag, 2001. [Google Scholar]
  27. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 1991; 86(9): 1119–27. [DOI] [PubMed] [Google Scholar]
  28. Hurt RD, Sachs DPL, Glower ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM. A comparison of sustained‐release bupropion and placebo for smoking cessation. New England Journal of Medicine 1997; 337: 1195–202. [DOI] [PubMed] [Google Scholar]
  29. Jäkle C, Keller S, Baum E, Basler H‐D. Skalen zur Selbstwirksamkeit und Entscheidungsbalance im Prozess der Verhaltensänderung von Rauchern. Diagnostica 1999; 45(3): 138–46. [Google Scholar]
  30. Jarvis MJ. Patterns and predictors of smoking cessation in the general population In Bolliger CT, Fagerström KO. (eds) The Tobacco Epidemic. Progress in Respiratory Research. Basel: Karger, 1997, pp. 115–64. [Google Scholar]
  31. John U, Hanke M. Tabakrauch‐attributable Mortalität in deutschen Bundesländern. Gesundheitswesen 2001; 63: 363–9. [DOI] [PubMed] [Google Scholar]
  32. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB. A controlled trial of sustained‐release Bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine 1999; 340: 685–91. [DOI] [PubMed] [Google Scholar]
  33. Junge B, Nagel M: Das Rauchverhalten in Deutschland. Gesundheitswesen 1999; 61 (suppl. 2): 121–5. [PubMed] [Google Scholar]
  34. Junge B, Thamm M. Jahrbuch Sucht 2003, Tabak – Zahlen und Fakten zum Konsum. Geesthacht: Neuland‐Verlag, 2001, pp. 34–61. [Google Scholar]
  35. Krause P, Wittchen H‐U, Höfler M, Winter S, Spiegel B, Pfister H. Generalisierte Angst und Depression in der Allgemeinarztpraxis (GAD‐P). Studiendesign und Methodik. MMW Fortschritte der Medizin 2001; 119 (suppl. 1): 5–12. [PubMed] [Google Scholar]
  36. Krause, P , Wittchen H‐U, Küpper B, Sharma AM, Ritz E, Göke B, Lehnert H, Unger T, Kirch W, Pittrow D, Tschöpe, D . The Hypertension and Diabetes Screening and Awareness Study (HYDRA): aims, design and methods of an innovative epidemiological approach. European Journal of Public Health 2002; 12 (suppl.): 70. [Google Scholar]
  37. Lachner G, Wittchen H‐U, Perkonigg A, Holly A, Schuster P, Wunderlich U, Türk D, Garczynski E, Pfister H. Structure, content and reliability of the Munich‐Composite International Diagnostic Interview (M‐CIDI). Substance use sections. European Addiction Research 1998; 4(1–2): 28–41. [DOI] [PubMed] [Google Scholar]
  38. Lachner G, Wittchen H‐U. Das Composite International Diagnostic Interview Substance Abuse Module (CIDISAM) In Mann K, Buchkremer G. (eds) Sucht. Grundlagen, Diagnostik, Therapie. Stuttgart: Gustav Fischer, 1996, pp. 147–56. [Google Scholar]
  39. Lieb RB, Isensee B, Von Sydow K, Wittchen H‐U. The Early Developmental Stages of Psychopathology Study (EDSP): a methodological update. European Addiction Research 2000; 6(4): 170–82. [DOI] [PubMed] [Google Scholar]
  40. Lieb R, Schuster P, Pfister H, Fuetsch M, Höfler M, Isensee B, Müller N, Sonntag H, Wittchen H‐U. Epidemiologie des Konsums, Mißbrauchs und der Abhängigkeit von legalen und illegalen Drogen bei Jugendlichen und jungen Erwachsenen: Die prospektiv‐longitudinale Verlaufsstudie EDSP. Sucht 2000; 46(1): 18–31. [Google Scholar]
  41. Loddenkemper R, Sybrecht GW. Health care costs of smoking. European Respiratory Journal 2000; 16: 377–8. [DOI] [PubMed] [Google Scholar]
  42. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269. [DOI] [PubMed] [Google Scholar]
  43. Nelson CB, Wittchen H‐U. Smoking and nicotine dependence: Results from a sample of 14 to 24 year olds in Germany. European Addiction Research 1998a; 4(1–2): 42–9. [DOI] [PubMed] [Google Scholar]
  44. Nelson CB, Wittchen H‐U. Editorial: The EDSP: Setting the Stage! European Addiction Research 1998b; 4 (1–2): 5–7. [DOI] [PubMed] [Google Scholar]
  45. Perkonigg A, Lieb R, Wittchen H‐U. Substance use, abuse and dependence in Germany: a review of selected epidemiological data. European Addiction Research 1998; 4(1–2): 8–17. [DOI] [PubMed] [Google Scholar]
  46. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. Trends in cigarette smoking in the US: projections to the year 2000. JAMA 1989, 261: 61–5. [PubMed] [Google Scholar]
  47. Prochaska JO, DiClemente CC. The transtheoretical approach In Norcross JC, Goldfried MR. (eds) Handbook of Psychotherapy Integration. New York: Basic Books, 1992. [Google Scholar]
  48. Prochaska JO, DiClemente CC, Velicer WF, Rossi JS. Standardized, individualized, interactive, and personalized self‐help programs for smoking cessation. Health Psychology 1993; 12: 399–405. [DOI] [PubMed] [Google Scholar]
  49. Ruff LK, Volmer T, Nowak D, Meyer A. The economic impact of smoking in Germany. European Respiratory Journal 2000; 16: 385–90. [DOI] [PubMed] [Google Scholar]
  50. Samet JH, Larson MJ, Horton NJ, Doyle K, Winter M, Saitz R. Linking alcohol‐ and drug‐dependent adults to primary medical care: a randomized controlled trial of a multi‐disciplinary health intervention in a detoxification unit. Addiction 2003; 98 (4): 509–16. [DOI] [PubMed] [Google Scholar]
  51. Schön S, Nowak D. Medikamentöse Verfahren zur Raucherentwöhnung. Suchtmedizin in Forschung und Praxis 2002; 3 (suppl.). [Google Scholar]
  52. Silagy C, Mant D, Fowler G, Lodge M. Meta‐analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139–42. [DOI] [PubMed] [Google Scholar]
  53. Sonntag H. Epidemiologie des Rauchens und der Nikotinabhängigkeit bei Adoleszenten und jungen Erwachsenen ‐ Eine 5‐Jahres prospektiv‐longitudinale Entwicklungsstudie an 3021 Personen aus der Allgemeinbevölkerung. Dissertation, München, 2001.
  54. Sonntag H, Hoch E, Jahn B, Spiegel B, Pfister H, Wittchen H‐U. Tabakentwöhnungsmaßnahmen in der allgemeinärztlichen Versorgung: Implementierung, Effektivität und Wege einer optimierten Allokation. Suchtmedizin in Forschung und Prakis 2003, 5: 137–41. [Google Scholar]
  55. Sonntag H, Kröger C, Shaw R. Setting up an information system on smoking cessation programmes. IFT Berichte Band Nr. 96. München: IFT Institut für Therapieforschung, 1998. [Google Scholar]
  56. Sonntag H, Pfister H, Wittchen H‐U. Rauchen und Nikotinabhängigkeit in Deutschland. Ergebnisse des bundesweiten Zusatz‐Surveys, Psychische Störungen' im Rahmen des Bundes‐Gesundheitssurveys, 1998.
  57. Sonntag H, Wittchen H‐U, Höfler M, Kessler RC, Stein MB. Are social fears and DSM‐IV social anxiety disorder associated with smoking and nicotine dependence in adolescents and young adults? European Psychiatry 2000; 15 (1): 67–74. [DOI] [PubMed] [Google Scholar]
  58. US Department of Health and Human Services . People Health: National Health Promotion and Disease Prevention Objectives. Full Report. Washington: Department of Health and Human Services, 1990. [Google Scholar]
  59. Üstün TB, Wittchen H‐U. Instruments for the assessment of substance use disorders. Current Opinion in Psychiatry 1992; 5: 412–19. [Google Scholar]
  60. Welte R, König HH, Leidl R. The costs of health damage and productivity losses attributable to cigarette smoking in Germany. Eur J Public Health 2000;10: 31–8. [Google Scholar]
  61. Winter S, Wittchen H‐U, Höfler M, Spiegel B, Ormel H, Müller N, Pfister H. Design und Methoden der Studie ‘Depression 2000’. MMW Fortschritte der Medizin 2000; 118 (suppl. 1): 11–21. [Google Scholar]
  62. Wittchen H‐U (ed). Depression 2000. Eine bundesweite Depressions‐Screening‐Studie in Allgemeinarztpraxen. MMW Fortschritte der Medizin 2000; 118 (suppl. I/2000). [Google Scholar]
  63. Wittchen H‐U (ed.) NISAS 2000: Die Nationwide Insomnia Screening and Awareness Study (NISAS). Prävalenz und Verschreibungsverhalten in der allgemeinärztlichen Versorgung. MMW Fortschritte der Medizin 2001; 119 (suppl. I/2001). [PubMed] [Google Scholar]
  64. Wittchen H‐U (ed.) GAD‐P‐Studie. Bundesweite Studie ‘Generalisierte Angst und Depression im primärärztlichen Bereich’. MMW Fortschritte der Medizin 2001; 119, (suppl I/2001). [PubMed] [Google Scholar]
  65. Wittchen H‐U (ed). Die Hypertension and Diabethes Awareness and Screening‐(HYDRA)‐Studie GAD‐PStudie. Bundesweite Studie ‘Generalisierte Angst und Depression im primärärztlichen Bereich’. MMW Fortschritte der Medizin 2003; 121 (suppl I/2003). [PubMed] [Google Scholar]
  66. Wittchen H‐U, Höfler M, Krause P, Riemann D. The Nationwide Insomnia Screening and Awareness Study (NISAS): Aims, methods and first findings. Abstract P.21.24. International Journal of Neuropsychopharmacology 2000; 3 (suppl. 1): 392. [Google Scholar]
  67. Wittchen H‐U, Höfler M, Meister W. Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? International Clinical Psychopharmacology 2001; 16 (3): 121–35. [DOI] [PubMed] [Google Scholar]
  68. Wittchen H‐U, Krause P, Höfler M, Winter S, Spiegel B, Hajak G, Riemann D, Pittrow D, Steiger A, Pfister H. NISAS‐2000 – die Nationale Insomnie Awareness und Screening Studie. Insomnien und Schlafstörungen in der allgemeinärztlichen Versorgung. Nervenheilkunde 2001b; 20 (1): 4–16. [PubMed] [Google Scholar]
  69. Wittchen HU, Nelson CB. Early developmental stages of substance abuse. European Addiction Research 1998; 4: 1–84. [DOI] [PubMed] [Google Scholar]
  70. Wittchen H‐U, Perkonigg A, Lachner G, Nelson C B. Early developmental stages of psychopathology study (EDSP) – objectives and design. European Addiction Research 1998; 4 (1–2): 18–27. [DOI] [PubMed] [Google Scholar]
  71. Wittchen H‐U, Pfister H. (eds) DIA‐X‐Interviews: Manual für Screening‐Verfahren und Interview. Frankfurt: Swets & Zeitlinger, 1997. [Google Scholar]
  72. Wittchen H‐U, Schuster P, Pfister, H , Müller N, Storz S, Isensee B. Depressionen in der Allgemeinbevölkerung – schlecht erkannt und selten behandelt. Nervenheilkunde 1999; 18: 202–9. [Google Scholar]
  73. Wittchen H‐U, Sonntag H, Nowak D, Kröger C, Schmidt LG. Raucherentwöhnung beim Hausarzt – Illusion oder Perspektive? Der Hausarzt 2002; 6: 49–53. [Google Scholar]
  74. World Health Organization (WHO) . The Composite International Diagnostic Interview (CIDI). Geneva: World Health Organization, Division of Mental Health, 1990. [Google Scholar]
  75. World Health Organization (WHO) . Tobacco or health: a global status report. Geneva: World Health Organization, 1997. [Google Scholar]
  76. World Health Organization (WHO) . Gemeinsam handeln – Tabakkonsum reduzieren: Dokumentation der Abschlusskonferenz des WHO‐Partnerschaftsprojektes Tabakabhängigkeit (1999‐2002). WHOKonferenzband. pdf in:http://www.1who‐nichtrauchertag.de, 2002.
  77. Zimmer D, Lindinger P, Mitschele U. Neue Wege in der verhaltenstherapeutischen Behandlung des Rauchens. Verhaltenstherapie 1993; 3: 304–11. [Google Scholar]

Articles from International Journal of Methods in Psychiatric Research are provided here courtesy of Wiley

RESOURCES